Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Biofourmis and HealthXL Report: Digital Endpoint Support for Pharma Label Claims Expected to Become Common Before 2030

    Nov 17, 2023, 10:44 AM by
    Biofourmis and HealthXL Report: Digital Endpoint Support for Pharma Label Claims Expected to Become Common Before 2030
    Full story
  • Unleashing the Power of Graphene-Silicon-Carbon Composites: Alfa Chemistry at the Forefront

    Nov 17, 2023, 10:44 AM by
    Full story
  • First Health Advisory announces partnership with Intrusion to combat cyber threats in healthcare

    Nov 17, 2023, 10:44 AM by
    Full story
  • CRISPR Screens: A New Frontier in Drug Discovery, Research

    Nov 17, 2023, 01:00 AM by User Not Found
    Bio-IT World | In 2012, Jennifer Doudna and Emmanuelle Charpentier at the University of California, Berkeley, and Feng Zhang at the Broad Institute of MIT and Harvard independently discovered that the CRISPR system could be used in human cells to target and edit DNA in a precise and programmable manner. This discovery revolutionized the field of genetic engineering and paved the way for the development of CRISPR screens.
    Full story
  • CD Formulation Introduces Powder Flowability Testing to Maximize Tablet Performance

    Nov 16, 2023, 09:38 AM by
    Full story
  • Alfa Chemistry Helps Partners Achieve mRNA Vaccine Excellence: Development, Production, Optimization, Quality Control

    Nov 16, 2023, 09:38 AM by
    Full story
  • Aranscia Acquires YouScript from Invitae

    Nov 16, 2023, 09:38 AM by
    Pioneering Pharmacogenomics Platform Joins Portfolio of Complementary Precision Medicine Workflow Solutions
    Full story
  • The NHS East Genomic Medicine Service Alliance Harnesses PhenoTips’ Genomic Health Record in a Milestone Regional Transformation Project

    Nov 16, 2023, 09:38 AM by
    The NHS East Genomic Medicine Service Alliance Harnesses PhenoTips’ Genomic Health Record in a Milestone Regional Transformation Project
    Full story
  • AppOmni Earns Spot on the CRN 2023 Stellar Startups List

    Nov 15, 2023, 09:10 AM by
    AppOmni, the market leader in SaaS Security Posture Management (SSPM) and pioneer of the SaaS security space, has been named to the CRN 2023 Stellar Startups list in the security category.
    Full story
  • Owkin’s Generative AI Vision for Understanding Biology

    Nov 15, 2023, 01:00 AM by User Not Found
    Bio-IT World | Generative AI in drug discovery is primarily a patient stratification play. Identifying which group of patients might best respond to a particular drug can still be foggy at best.
    Full story
  • FDB Recognized by AMIA for Decades-Long Partnership & Contributions to Healthcare Informatics

    Nov 14, 2023, 09:17 AM by
    FDB Recognized by AMIA for Decades-Long Partnership & Contributions to Healthcare Informatics for providing drug knowledge that helps healthcare professionals make precise decisions
    Full story
  • Multicenter Validation of the Novel Vivio® System for Non-Invasive Estimation of Elevated Left Ventricular End Diastolic Pressure

    Nov 14, 2023, 09:17 AM by
    Findings presented at the 2023 American Heart Association Scientific Symposium: Multicenter Validation of the Novel Vivio® System for Non-Invasive Estimation of Elevated Left Ventricular End Diastolic Pressure
    Full story
  • Researchers gain deeper spatial insights with multiplexed 2D image analysis tool

    Nov 14, 2023, 09:17 AM by
    The latest release of Aivia AI Image Analysis Software offers accurate multiplex cell detection and automatic clustering with up to 30 markers
    Full story
  • Pharma’s Tech Partner Wish List

    Nov 14, 2023, 01:00 AM by User Not Found
    Bio-IT World | What is pharma looking for in technology partners? That was the question posed to a panel representing Pfizer, Johnson & Johnson, GlaxoSmithKline, and AstraZeneca last month at the HLTH Conference. The answers revealed some of the trends these pharma companies expect to see in drug development and clinical trials, and the pain points they are actively addressing now.
    Full story
  • Biopharma PEG Elevates ADC Development with Monodispersed PEGs in Versatile Scales

    Nov 13, 2023, 08:55 AM by
    Biopharma PEG introduces monodispersed PEGs, including mPEG36-NH2,NH2-PEG24-COOH, OH-PEG9-OH, mPEG8-SPA , for ADC development at diverse scales. R&D Director highlights their role in modulating ADC properties.
    Full story
  • Huateng Pharma Elevates Diabetes Drug Development with High-Purity Anti-Diabetes Intermediates

    Nov 13, 2023, 08:55 AM by
    Huateng Pharma introduces advanced anti-diabetes intermediates, such as Canagliflozin, Dapagliflozin, Empagliflozin, and Semaglutide, representing a major step in diabetes treatment. These high-purity compounds have the potential to revolutionize drug development. Huateng Pharma also offers CDMO services to promote collaboration in the pharmaceutical industry.
    Full story
  • NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

    Nov 10, 2023, 06:58 AM by
    NSF has announced that that Novozymes has become the world’s first company to implement NSF TraQtion software for managing the quality and compliance of raw materials used in the production of enzymes and proteins serving multiple industries.
    Full story
  • Medix Biochemica expands its infectious diseases antibody offering through the acquisition of ViroStat

    Nov 10, 2023, 06:58 AM by
    Medix Biochemica has acquired 100 percent of the shares of ViroStat.
    Full story
  • 1upHealth Ranked Number 35 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

    Nov 9, 2023, 08:51 AM by
    Full story
  • Kalderos Strengthens C-Suite by Naming New CFO, CTO and CISO

    Nov 9, 2023, 08:51 AM by
    Kalderos Strengthens C-Suite by Naming New CFO, CTO and CISO
    Full story
  • «
  • 71
  • 72
  • 73
  • 74
  • 75 (current)
  • 76
  • 77
  • 78
  • 79
  • 80
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy